Lantern Pharma Inc (LTRN)
6.13
-0.01
(-0.16%)
USD |
NASDAQ |
May 17, 16:00
6.00
-0.13
(-2.12%)
After-Hours: 20:00
Lantern Pharma Enterprise Value: 26.52M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 26.52M |
| May 16, 2024 | 27.70M |
| May 15, 2024 | 29.75M |
| May 14, 2024 | 28.24M |
| May 13, 2024 | 27.16M |
| May 10, 2024 | 27.92M |
| May 09, 2024 | 34.91M |
| May 08, 2024 | 31.36M |
| May 07, 2024 | 30.71M |
| May 06, 2024 | 35.34M |
| May 03, 2024 | 27.81M |
| May 02, 2024 | 20.71M |
| May 01, 2024 | 19.63M |
| April 30, 2024 | 16.51M |
| April 29, 2024 | 14.68M |
| April 26, 2024 | 20.82M |
| April 25, 2024 | 20.39M |
| April 24, 2024 | 19.52M |
| April 23, 2024 | 23.72M |
| April 22, 2024 | 23.18M |
| April 19, 2024 | 19.09M |
| April 18, 2024 | 23.72M |
| April 17, 2024 | 26.09M |
| April 16, 2024 | 26.19M |
| April 15, 2024 | 25.87M |
| Date | Value |
|---|---|
| April 12, 2024 | 30.39M |
| April 11, 2024 | 33.40M |
| April 10, 2024 | 44.92M |
| April 09, 2024 | 45.13M |
| April 08, 2024 | 45.45M |
| April 05, 2024 | 45.13M |
| April 04, 2024 | 39.32M |
| April 03, 2024 | 54.60M |
| April 02, 2024 | 60.09M |
| April 01, 2024 | 63.96M |
| March 28, 2024 | 53.22M |
| March 27, 2024 | 63.75M |
| March 26, 2024 | 66.43M |
| March 25, 2024 | 65.25M |
| March 22, 2024 | 73.09M |
| March 21, 2024 | 55.69M |
| March 20, 2024 | 53.22M |
| March 19, 2024 | 39.15M |
| March 18, 2024 | 65.68M |
| March 15, 2024 | 52.15M |
| March 14, 2024 | 37.65M |
| March 13, 2024 | 32.70M |
| March 12, 2024 | 41.41M |
| March 11, 2024 | 26.58M |
| March 08, 2024 | 47.53M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-17.97M
Minimum
Oct 31 2023
225.72M
Maximum
Mar 17 2021
34.54M
Average
7.592M
Median
Jul 06 2023
Enterprise Value Benchmarks
| Eyenovia Inc | 47.34M |
| Cassava Sciences Inc | 985.04M |
| Alpine Immune Sciences Inc | 4.151B |
| Clearside Biomedical Inc | 62.54M |
| Poseida Therapeutics Inc | 169.34M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.441M |
| Total Expenses (Quarterly) | 5.732M |
| EPS Diluted (Quarterly) | -0.51 |
| Earnings Yield | -27.03% |